VANDEPUTTE MEDICAL BENELUX
0839.194.312 · rovalta.com · 27/09/2026
VANDEPUTTE MEDICAL BENELUX
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBOVANDEPUTTE MEDICAL BENELUX is a Public limited company incorporated in 2011. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Kontich.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0839.194.312
- Incorporation
- 09/09/2011
- Legal form
- Public limited company
- Registered office
- Antwerpsesteenweg 61
2550 Kontich · FlandreSee on map - Contributed capital
- 500 000,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 14 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 60 k € | -73.7% | 228 k € | -28.3% | 318 k € | +11.4% | 285,5 k € | +43.3% | 199,2 k € |
| EBITDA | 27,8 k € | -2.2% | 28,5 k € | +2.6% | 27,7 k € | -70.3% | 93,5 k € | +221% | -77,5 k € |
| Operating result | 27,8 k € | -2.2% | 28,5 k € | +2.6% | 27,7 k € | -70.3% | 93,5 k € | +221% | -77,5 k € |
| Net result | 277,5 k € | -47.8% | 531,6 k € | -31.8% | 779,2 k € | -14.4% | 910 k € | -1.2% | 921,4 k € |
| Balance sheet | |||||||||
| Equity | 2,6 M € | +1.1% | 2,6 M € | -7.8% | 2,8 M € | +15.6% | 2,4 M € | -3.6% | 2,5 M € |
| Total assets | 3,6 M € | +8.0% | 3,4 M € | +0.4% | 3,3 M € | +13.2% | 3 M € | -4.4% | 3,1 M € |
| Cash | 119,4 k € | +99.2% | 59,9 k € | -22.8% | 77,7 k € | -7.9% | 84,3 k € | -85.8% | 594,8 k € |
| Debts | 1 M € | +31.5% | 767,3 k € | +42.9% | 536,8 k € | +2.0% | 526,1 k € | -8.3% | 573,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/2025Other companies at this address
Antwerpsesteenweg 61 2550 Kontich| Company | CBE no. |
|---|---|
Carla● Active | 0745.384.424 |
PASTIS INVEST● Active | 0778.755.293 |
SOORS INVEST● Active | 0459.566.006 |
VANINVEST● Active | 0466.997.887 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 15 months | 12 months |
| Filing date | 17/03/2026 | 18/03/2025 | 19/04/2024 | 27/04/2023 | 02/05/2022 | 28/01/2021 |
| General meeting | 10/03/2026 | 11/03/2025 | 12/03/2024 | 14/03/2023 | 02/05/2022 | 08/09/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 30/09/2025 | 10/03/2026 | 17/03/2026 | Dutch | |
| Full model | 30/09/2024 | 11/03/2025 | 18/03/2025 | Dutch | |
| Full model | 30/09/2023 | 12/03/2024 | 19/04/2024 | Dutch | |
| Full model | 30/09/2022 | 14/03/2023 | 27/04/2023 | Dutch | |
| Full model | 30/09/2021 | 02/05/2022 | 02/05/2022 | Dutch | |
| Full model | 30/06/2020 | 08/09/2020 | 28/01/2021 | Dutch | |
| Full model | 30/06/2019 | 10/09/2019 | 29/10/2019 | Dutch | |
| Full model | 30/06/2018 | 11/09/2018 | 31/10/2018 | Dutch | |
| Full model | 30/06/2017 | 12/09/2017 | 29/09/2017 | Dutch | |
| Full model | 30/06/2016 | 13/09/2016 | 27/10/2016 | Dutch | |
| Full model | 30/06/2015 | 08/09/2015 | 11/01/2016 | Dutch | |
| Full model | 30/06/2014 | 09/09/2014 | 31/10/2014 | Dutch | |
| Full model | 30/06/2013 | 10/09/2013 | 18/09/2013 | Dutch | |
| Full model | 30/06/2012 | 14/12/2012 | 24/12/2012 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/2025Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates18/12/2025ONTSLAGEN - BENOEMINGEN
- Mandates22/11/2024ONTSLAGEN - BENOEMINGEN
- Mandates01/07/2024ONTSLAGEN - BENOEMINGEN
- Mandates24/03/2023ONTSLAGEN - BENOEMINGEN
- Mandates12/12/2022ONTSLAGEN - BENOEMINGEN
- Other23/11/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING
- Mandates10/05/2021ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
- Registered office09/03/2021MAATSCHAPPELIJKE ZETEL
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025277,5 k €↓
- 2024Annual accounts 2024531,6 k €↓
- 2023Annual accounts 2023779,2 k €↓
- 2022Annual accounts 2022910 k €↓
- 2022Name changeVandeputte Medical Benelux
- 2021Annual accounts 2021921,4 k €↑
- 2021Name changeMatomedi
- 2019Annual accounts 2019103,1 k €↓
- 2018Annual accounts 20182,2 M €↑
- 2017Annual accounts 2017-118,5 k €↓
- 2016Annual accounts 2016-82 k €
- 09/09/2011IncorporationPublic limited company